Foreign-Trade Zone (FTZ) 22-Chicago, Illinois; Notification of Proposed Production Activity; AbbVie, Inc. (Pharmaceutical Products); North Chicago and Lake County, Illinois, 41008 [2021-16295]

Download as PDF 41008 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [Order No. 2115] Reorganization of Foreign-Trade Zone 114 Under Alternative Site Framework Peoria, Illinois lotter on DSK11XQN23PROD with NOTICES1 Pursuant to its authority under the ForeignTrade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a–81u), the ForeignTrade Zones Board (the Board) adopts the following Order: Whereas, the Foreign-Trade Zones (FTZ) Act provides for ‘‘. . . the establishment . . . of foreign-trade zones in ports of entry of the United States, to expedite and encourage foreign commerce, and for other purposes,’’ and authorizes the Board to grant to qualified corporations the privilege of establishing foreign-trade zones in or adjacent to U.S. Customs and Border Protection ports of entry; Whereas, the Board adopted the alternative site framework (ASF) (15 CFR 400.2(c)) as an option for the establishment or reorganization of zones; Whereas, the Economic Development Council, Inc., grantee of Foreign-Trade Zone 114, submitted an application to the Board (FTZ Docket B–1–2021, docketed January 8, 2021) for authority to reorganize under the ASF with a service area of Peoria, Cass, Champaign, Dewitt, Ford, Fulton, Knox, Livingston, Logan, Macon, Marshall, Mason, McDonough, McLean, Menard, Piatt, Putnam, Sangamon, Schuyler, Stark, Tazewell, Woodford Counties and portions of Bureau and LaSalle Counties, Illinois, in and adjacent to the Peoria Customs and Border Protection port of entry, FTZ 114’s existing Sites 7 and 8 would be categorized as magnet sites, existing Site 9 would be removed from the zone, existing Sites 1, 2, 4, 5 and 6 would be categorized as usagedriven sites, and the grantee proposes an initial ASF Subzone with three sites (Subzone 114H); Whereas, notice inviting public comment was given in the Federal Register 86 FR 3117, January 14, 2021) and the application has been processed pursuant to the FTZ Act and the Board’s regulations; and, Whereas, the Board adopts the findings and recommendations of the examiner’s report, and finds that the requirements of the FTZ Act and the Board’s regulations are satisfied; Now, therefore, the Board hereby orders: The application to reorganize FTZ 114 under the ASF is approved, subject to VerDate Sep<11>2014 17:24 Jul 29, 2021 Jkt 253001 the FTZ Act and the Board’s regulations, including Section 400.13, to the Board’s standard 2,000-acre activation limit for the zone, to an ASF sunset provision for magnet sites that would terminate authority for Sites 7 and 8 if not activated within five years from the month of approval, and to an ASF sunset provision for subzone/usagedriven sites that would terminate authority for Sites 1, 2, 4, 5 and 6 as well as Sites 1–3 of Subzone 114H if no foreign-status merchandise is admitted for a bona fide customs purpose within three years from the month of approval. Dated: July 26, 2021. Christian B. Marsh, Acting Assistant Secretary for Enforcement and Compliance, Alternate Chairman, Foreign-Trade Zones Board. [FR Doc. 2021–16251 Filed 7–29–21; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–55–2021] Foreign-Trade Zone (FTZ) 22— Chicago, Illinois; Notification of Proposed Production Activity; AbbVie, Inc. (Pharmaceutical Products); North Chicago and Lake County, Illinois AbbVie, Inc. (AbbVie), submitted a notification of proposed production activity to the FTZ Board for its facilities in North Chicago and Lake County, Illinois. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on July 16, 2021. AbbVie already has authority to produce pharmaceutical products within Subzone 22S. The current request would add a finished product and foreign status materials to the scope of authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited to the specific foreignstatus materials and specific finished product described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt AbbVie from customs duty payments on the foreign-status materials/components used in export production. On its domestic sales, for the foreign-status materials/components noted below and in the existing scope of authority, AbbVie would be able to choose the duty rates during customs entry procedures that apply to upadacitinib intermediate material (duty rate 6.5%). AbbVie would be able to avoid duty on foreign-status PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 components which become scrap/waste. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The materials sourced from abroad are 2-Amino-3,5-dibromopyrazine and potassium tert-butylate (duty rate ranges from 3.7 to 6.5%). The request indicates that the foreign-status materials are subject to duties under Section 301 of the Trade Act of 1974 (Section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is September 8, 2021. A copy of the notification will be available for public inspection in the ‘‘Reading Room’’ section of the Board’s website, which is accessible via www.trade.gov/ftz. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov. Dated: July 27, 2021. Andrew McGilvray, Executive Secretary. [FR Doc. 2021–16295 Filed 7–29–21; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE International Trade Administration [A–821–831] Investigation of Urea Ammonium Nitrate Solutions From the Russian Federation: Opportunity To Comment on the Russian Federation’s Status as a Market Economy Country Under the Antidumping Duty Laws Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: As part of the less-than-fairvalue investigation of urea ammonium nitrate solutions (UAN) from the Russian Federation (Russia), we found that the petitioner has provided sufficient evidence for the Department of Commerce (Commerce) to examine whether to continue to treat Russia as a market economy (ME) country for purposes of the antidumping duty law. As a result, Commerce is seeking public comment and information with respect to the relevant statutory factors. DATES: To be assured of consideration, written comments and information must AGENCY: E:\FR\FM\30JYN1.SGM 30JYN1

Agencies

[Federal Register Volume 86, Number 144 (Friday, July 30, 2021)]
[Notices]
[Page 41008]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16295]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-55-2021]


Foreign-Trade Zone (FTZ) 22--Chicago, Illinois; Notification of 
Proposed Production Activity; AbbVie, Inc. (Pharmaceutical Products); 
North Chicago and Lake County, Illinois

    AbbVie, Inc. (AbbVie), submitted a notification of proposed 
production activity to the FTZ Board for its facilities in North 
Chicago and Lake County, Illinois. The notification conforming to the 
requirements of the regulations of the FTZ Board (15 CFR 400.22) was 
received on July 16, 2021.
    AbbVie already has authority to produce pharmaceutical products 
within Subzone 22S. The current request would add a finished product 
and foreign status materials to the scope of authority. Pursuant to 15 
CFR 400.14(b), additional FTZ authority would be limited to the 
specific foreign-status materials and specific finished product 
described in the submitted notification (as described below) and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt AbbVie from customs 
duty payments on the foreign-status materials/components used in export 
production. On its domestic sales, for the foreign-status materials/
components noted below and in the existing scope of authority, AbbVie 
would be able to choose the duty rates during customs entry procedures 
that apply to upadacitinib intermediate material (duty rate 6.5%). 
AbbVie would be able to avoid duty on foreign-status components which 
become scrap/waste. Customs duties also could possibly be deferred or 
reduced on foreign-status production equipment.
    The materials sourced from abroad are 2-Amino-3,5-dibromopyrazine 
and potassium tert-butylate (duty rate ranges from 3.7 to 6.5%). The 
request indicates that the foreign-status materials are subject to 
duties under Section 301 of the Trade Act of 1974 (Section 301), 
depending on the country of origin. The applicable Section 301 
decisions require subject merchandise to be admitted to FTZs in 
privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is September 8, 
2021.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: July 27, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-16295 Filed 7-29-21; 8:45 am]
BILLING CODE 3510-DS-P